Lang Tieming, Dalal Shibani, Chikova Anna, DiMaio Daniel, Sweasy Joann B
Department of Therapeutic Radiology, Yale University School of Medicine, 15 York Street, P.O. Box 20840, New Haven, CT 06520, USA.
Mol Cell Biol. 2007 Aug;27(15):5587-96. doi: 10.1128/MCB.01883-06. Epub 2007 May 25.
Approximately 30% of human tumors examined for mutations in polymerase beta (pol beta) appear to express pol beta variant proteins (D. Starcevic, S. Dalal, and J. B. Sweasy, Cell Cycle 3:998-1001, 2004). Many of these variants result from a single amino acid substitution. We have previously shown that the K289M and I260M colon and prostate cancer variants, respectively, induce cellular transformation most likely due to sequence-specific mutator activity (S. Dalal et al., Biochemistry 44:15664-15673, 2005; T. Lang et al., Proc. Natl. Acad. Sci. USA 101:6074-6079, 2004; J. B. Sweasy et al., Proc. Natl. Acad. Sci. USA 102:14350-14355, 2005). In the work described here, we show that the E295K gastric carcinoma pol beta variant acts in a dominant-negative manner by interfering with base excision repair. This leads to an increase in sister chromatid exchanges. Expression of the E295K variant also induces cellular transformation. Our data suggest that unfilled gaps are channeled into a homology-directed repair pathway that could lead to genomic instability. The results indicate that base excision repair is critical for maintaining genome stability and could therefore be a tumor suppressor mechanism.
在检测过聚合酶β(pol β)突变的人类肿瘤中,约30%似乎表达pol β变异蛋白(D. Starcevic、S. Dalal和J. B. Sweasy,《细胞周期》3:998 - 1001,2004年)。这些变异中有许多是由单个氨基酸替换导致的。我们之前已经表明,K289M和I260M结肠和前列腺癌变异体分别最有可能由于序列特异性诱变活性而诱导细胞转化(S. Dalal等人,《生物化学》44:15664 - 15673,2005年;T. Lang等人,《美国国家科学院院刊》101:6074 - 6079,2004年;J. B. Sweasy等人,《美国国家科学院院刊》102:14350 - 14355,2005年)。在此处描述的研究中,我们表明E295K胃癌pol β变异体通过干扰碱基切除修复以显性负性方式起作用。这导致姐妹染色单体交换增加。E295K变异体的表达也诱导细胞转化。我们的数据表明,未填补的缺口被导向同源定向修复途径,这可能导致基因组不稳定。结果表明,碱基切除修复对于维持基因组稳定性至关重要,因此可能是一种肿瘤抑制机制。